Dr. Salitha Sunderrajan, MD

Dr. Sunderrajan practices at Zuckerberg San Francisco General Hospital and Trauma Center in San Francisco, California, part of City and County of San Francisco, CA.

Dr. Sunderrajan's NPI, 1417185919, was assigned on June 23, 2009. Dr. Sunderrajan graduated from New York Medical College in 2009. Dr. Sunderrajan's California license number on file is A117158.

Dr. Sunderrajan's primary practice is Zuckerberg San Francisco General Hospital and Trauma Center, at 1001 Potrero Avenue, San Francisco, CA 94110 in San Francisco County. The practice phone is (415) 206-8000.

Dr. Sunderrajan's primary practice is Zuckerberg San Francisco General Hospital and Trauma Center in San Francisco, California, part of City and County of San Francisco, CA. Dr. Sunderrajan is also affiliated with UCSF Helen Diller Medical Center at Parnassus Heights. The medical group on file is UCSF Department of Radiology & Biomedical Imaging. Dmand AI also links Dr. Sunderrajan to 1 more hospital, 2 dialysis centers, 2 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sunderrajan practices, 6 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Sunderrajan's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Sunderrajan is board certified in internal medicine by the American Board of Internal Medicine. Dr. Sunderrajan has a license on file in California.

Dmand AI lists acute kidney failure, chronic kidney disease, fluid and electrolyte imbalances, kidney cysts and kidney disease among the conditions Dr. Sunderrajan treats.

CMS data shows 176 Medicare services from Dr. Sunderrajan across 3 procedure codes in 2024, for 99 Medicare patients. Medicare paid $15,782 for them. Every service was in an office.

CMS counts 99 Medicare patients who saw Dr. Sunderrajan in 2024. The largest group is 75 to 84, with 54 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 23% are also on Medicaid. Their average risk score is 2.07, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sunderrajan's median patient age at 72, with 46% women.

In 2024, Dr. Sunderrajan wrote 313 Medicare Part D claims for 74 patients. 84% of them were for generic drugs. CMS names the drug for 201 of them, across 8 drugs with 11 or more claims each, at $22,592 in total drug cost. In 2023, CMS named 544 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Sunderrajan for performance year 2024. Dr. Sunderrajan accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 14 general payments to Dr. Sunderrajan from 7 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 89% of the total. AstraZeneca Pharmaceuticals LP paid the most, $88.

Dr. Sunderrajan graduated from New York Medical College in 2009.

Dr. Sunderrajan is in network with 6 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.